Using CRISPR-Q<sub>KD</sub>, we achieve effective knockdown of smn1 and simultaneous knockdown of tardbp and tardbpl, modeling spinal muscular atrophy and amyotrophic lateral sclerosis, respectively. This evidence concerns the gene SMN1 and proximal spinal muscular atrophy.